Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Leo Pharma (Denmark) | Researchclopedia

Back to institutions

Leo Pharma (Denmark)

Ballerup Municipality, Capital Regioncompany

1,397

Works

99,941

Citations

125

h-index

Top Research Topics

Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Asthma and respiratory diseases

Top Researchers

Henrik Toft Sørensen Aarhus University Hospital

2,299 works110,699 citationsh-index: 145

Recent Research

Superior efficacy and comparable safety of calcipotriol plus betamethasone dipropionate foam vs. ointment in Chinese patients with plaque psoriasis: A randomized phase 3 trial

Le Cai,F. Zhang,et al.

20260 citations

Contact Dermatitis and Allergies

Allergic Rhinitis and Sensitization

Vitamin D Research Studies

Advancements in Transdermal Drug Delivery

Health Systems, Economic Evaluations, Quality of Life

Pharmaceutical studies and practices

Urticaria and Related Conditions

Food Allergy and Anaphylaxis Research

Nonmelanoma Skin Cancer Studies

Lars G. Svensson Cleveland Clinic

1,211 works77,298 citationsh-index: 121

Jeffrey I. Weitz McMaster University Medical Centre

773 works74,005 citationsh-index: 118

H. Phillip Koeffler Cedars-Sinai Medical Center

1,107 works64,594 citationsh-index: 122

Éric Vivier Centre National de la Recherche Scientifique

692 works61,851 citationsh-index: 124

Paul Dieppe University of Exeter

644 works54,026 citationsh-index: 99

Safety and Adverse Events of Special Interest in 825 Adults With Atopic Dermatitis Receiving Up to 12 Months of Tralokinumab Treatment in a Real-World Setting

Cory Rubin,Abel Jarell,et al.

20260 citations

Real-World Safety and Effectiveness of Up to 12 Months of Tralokinumab Treatment in Adults With Atopic Dermatitis Who Discontinued Dupilumab Due to Conjunctivitis

April Armstrong,Cory Rubin,et al.

20260 citations

Reduced Dosing Frequency With Tralokinumab Provides Sustained Improvements in Symptoms and Quality of Life Up to 1 Year in Adults With Moderate-to-Severe AD

April W. Armstrong,Leon Kircik,et al.

20260 citations

Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement

Benjamin Ehst,Leon Kircik,et al.

20260 citations

Tralokinumab versus Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis with Hand Involvement: a Matching-Adjusted Indirect Comparison

April Armstrong,Leon Kircik,et al.

20260 citations